RT
Rein Therapeutics Inc
🇺🇸XNAS.RNTXUnited StatesHealthcare
$0.70USDdown -0.01 (-1.41%)ClosedEnd of day6:49 AM
Price$0.70-0.01 (-1.41%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US00887A2042
- CUSIP
- 00887A204
Company
- Employees
- 10
- Headquarters
- Austin, United States
- Website
- https://www.reintx.com
- CEO
- Dr. James Brian Windsor Ph.D.
Market
- Shares outstanding
- 86.3M
- Market cap
- $60.39M
Highlights
- Market cap
- $60.39M
- EPS LTM
- -$1.64
- P/E LTM
- -0.63
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $00%unchanged year on year
- Net income
- -$49.76M+15.87%up year on year
- Gross margin
- Not reported
- Free cash flow
- -$18.83M+11.27%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.